Trials / Completed
CompletedNCT01102244
A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 122 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the clinical efficacy and safety of Tobradex ST compared to AzaSite in the treatment of moderate to severe chronic blepharitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tobradex ST | tobramycin / dexamethasone ophthalmic suspension 0.3%/0.05% 1 drop 4 times daily for 14 days |
| DRUG | Azasite | azithromycin 1% 1 drop twice daily for 2 days, then once daily for 12 days |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2010-06-01
- First posted
- 2010-04-13
- Last updated
- 2012-06-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01102244. Inclusion in this directory is not an endorsement.